UK markets open in 42 minutes
  • NIKKEI 225

    29,563.17
    -204.89 (-0.69%)
     
  • HANG SENG

    28,389.98
    -308.82 (-1.08%)
     
  • CRUDE OIL

    59.01
    -0.31 (-0.52%)
     
  • GOLD FUTURES

    1,738.80
    -6.00 (-0.34%)
     
  • DOW

    33,800.60
    +297.00 (+0.89%)
     
  • BTC-GBP

    43,940.75
    +10.07 (+0.02%)
     
  • CMC Crypto 200

    1,288.49
    +60.95 (+4.97%)
     
  • ^IXIC

    13,900.19
    +70.89 (+0.51%)
     
  • ^FTAS

    3,949.51
    -11.46 (-0.29%)
     

The Worldwide Nuclear Imaging Equipment Industry is Projected to Reach $4.6 Billion by 2025 at a CAGR of 3.9% From 2020

Research and Markets
·7-min read

Dublin, March 12, 2021 (GLOBE NEWSWIRE) -- The "Nuclear Imaging Equipment Market by Product (SPECT (Hybrid SPECT, Standalone SPECT), Hybrid PET, & Planar Scintigraphy), Application (Oncology, Cardiology & Neurology) & End user (Hospitals, Imaging Centers) - Global Forecasts to 2025" report has been added to ResearchAndMarkets.com's offering.

The global nuclear imaging equipment market is projected to reach USD 4,604.9 million by 2025 from an estimated USD 3,803.5 million in 2020, at a CAGR of 3.9% during the forecast period.

Growth in the market can primarily be attributed to factors such as shift from standalone to hybrid modalities, advances in radiotracers, the increasing focus on personalized medicine, investments through public-private partnerships to modernize diagnostic imaging centers, and the increasing incidence and prevalence of cancer and cardiac ailments.

The SPECT imaging systems segment to hold the largest market share in 2020.

Based on product, the nuclear imaging equipment market is segmented into hybrid PET imaging systems, SPECT imaging systems, and planar scintigraphy imaging systems. The SPECT imaging systems segment is further categorized into standalone and hybrid imaging systems. The SPECT imaging systems segment is expected to the largest share in 2019. The large share of this segment can be attributed to high adoption of SPECT imaging systems on account of lower cost as compared to hybrid PET imaging systems.

The oncology segment to hold the largest market share in 2020.

Based on application, the nuclear imaging equipment market is segmented into oncology, cardiology, neurology, and other applications. The oncology application segment is expected to register the highest CAGR during the forecast period. The major factors contributing to the growth of this segment include the rising incidence and prevalence of cancer across the globe, initiatives taken by public and private organizations to curb the rising cancer prevalence, and the development of advanced systems and radiotracers for oncology.

The hospitals segment to hold the largest market share in 2020.

Based on end user, the nuclear imaging equipment market is segmented into hospitals, imaging centers, academic & research centers, and other end users. Hospitals accounted for the largest share of the global nuclear imaging equipment market in 2019. This can be attributed to factors such as the need to improve the efficiency of diagnostic imaging procedures and the rising number of diagnostic imaging procedures performed in hospitals.

The Asia Pacific region to witness the highest growth during the forecast period.

Geographically, North America dominated the global nuclear imaging equipment market in 2020. However, the Asia Pacific market is expected to register the highest during the forecast period. The major factors driving the growth of the Asia Pacific market include increasing incidence of chronic diseases, rising awareness on the benefits of early disease diagnosis, and improvement of healthcare systems in the region.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Nuclear Imaging Equipment Overview
4.2 North America: Nuclear Imaging Equipment Market, by Product & Country (2019)
4.3 Nuclear Imaging Equipment Market Share, by Product, 2020 Vs. 2025
4.4 Nuclear Imaging Equipment Market: Geographic Growth Opportunities

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rapidly Growing Geriatric Population and the Subsequent Increase in the Prevalence of Associated Diseases
5.2.1.2 Shift from Standalone to Hybrid Modalities
5.2.1.3 Increasing Focus on Personalized Medicine
5.2.2 Restraints
5.2.2.1 High Cost of Diagnostic Imaging Systems
5.2.2.2 Declining Reimbursements and Increasing Regulatory Burden in the US
5.2.3 Opportunities
5.2.3.1 High Growth Opportunities in Emerging Countries
5.2.3.2 Growing Demand for Data Integrated Imaging Systems
5.2.4 Challenges
5.2.4.1 Hospital Budget Cuts
5.3 Pricing Analysis
5.4 Porter's Five Forces Analysis
5.4.1 Bargaining Power of Buyers
5.4.2 Bargaining Power of Suppliers
5.4.3 Threat of New Entrants
5.4.4 Threat of Substitutes
5.4.5 Intensity of Competitive Rivalry
5.5 Impact of COVID-19 on the Nuclear Imaging Equipment Market
5.6 Value Chain Analysis
5.6.1 Research & Development
5.6.2 Manufacturing & Assembly
5.6.3 Distribution, Marketing & Sales, and Post-Sales Services
5.7 Supply Chain Analysis
5.7.1 Prominent Companies
5.7.2 Small & Medium-Sized Enterprises
5.7.3 End-users

6 Nuclear Imaging Equipment Market, by Product
6.1 Introduction
6.2 Single-Photon Emission Computed Tomography (Spect) Imaging Systems
6.2.1 Hybrid SPECT Imaging Systems
6.2.1.1 Growing Preference for Dual-Modality Hybrid Systems to Drive Market Growth
6.2.2 Standalone SPECT Imaging Systems
6.2.2.1 Low Cost of Standalone SPECT Imaging Systems is a Key Factor Driving Market Growth
6.3 Hybrid PET Imaging Systems
6.3.1 High Cost of Hybrid PET Imaging Systems to Limit Market Growth During the Forecast Period
6.4 Planar Scintigraphy Imaging Systems
6.4.1 Low Specificity of Planar Scintigraphy Imaging Systems to Limit Market Growth

7 Nuclear Imaging Equipment Market, by Application
7.1 Introduction
7.1.1 Oncology
7.1.1.1 Nuclear Imaging Systems Can Distinguish Between Benign and Malignant Tumors, Which Helps in Precise Diagnosis
7.1.2 Cardiology
7.1.2.1 High Prevalence of CVD is the Major Factor Driving the Growth of this Segment
7.1.3 Neurology
7.1.3.1 Increasing Demand for Nuclear Imaging in Diagnosing Neurological Disorders is Supporting the Growth of this Segment
7.1.4 Other Applications

8 Nuclear Imaging Equipment Market, by End-user
8.1 Introduction
8.2 Hospitals
8.2.1 Rising Trend of Modernizing Imaging Workflow is Driving the Adoption of Imaging Systems Among Hospitals
8.3 Imaging Centers
8.3.1 Growing Number of Private Imaging Centers to Support Market Growth
8.4 Academic & Research Centers
8.4.1 Increasing Collaborations Between Nuclear Imaging Companies and Academia to Propel Market Growth
8.5 Other End-users

9 Nuclear Imaging Equipment Market, by Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 the US Holds the Largest Share of the North American Market
9.2.2 Canada
9.2.2.1 a Dearth of Radiologists and Long Wait Times for Scans Are the Major Challenges in the Canadian Market
9.3 Europe
9.3.1 Eu3
9.3.1.1 Eu3 Holds the Largest Share of the Market in Europe
9.3.2 Russia
9.3.2.1 Initiatives to Improve Healthcare to Boost the Market Growth
9.3.3 RoE
9.4 Asia-Pacific
9.4.1 Japan
9.4.1.1 Growing Investments by Key Market Players to Drive Market Growth
9.4.2 China
9.4.2.1 Increasing Healthcare Reforms and the Rapidly Growing Aging Population to Drive Market Growth in China
9.4.3 India
9.4.3.1 Uncertainties in Healthcare Policies to Restrain Market Growth in India
9.4.4 Rest of Asia-Pacific
9.5 Rest of the World

10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Leadership Mapping
10.3.1 Stars
10.3.2 Emerging Leaders
10.3.3 Pervasive
10.3.4 Emerging Companies
10.4 Competitive Scenario
10.4.1 Product Launches
10.4.2 Acquisitions
10.4.3 Agreements, Partnerships, & Collaborations

11 Company Profiles
11.1 Siemens Healthineers
11.2 GE Healthcare
11.3 Koninklijke Philips N.V.
11.4 Digirad Corporation
11.5 Neusoft Medical Systems Co. Ltd.
11.6 Canon Inc.
11.7 Surgiceye Gmbh
11.8 DDD-Diagnostic A/S
11.9 CMR Naviscan Corporation
11.10 Mediso Ltd.
11.11 Shimadzu Corporation
11.12 Perkinelmer, Inc.
11.13 Milabs B.V.
11.14 MR Solutions Ltd.

12 Appendix
12.1 Discussion Guide
12.2 Knowledge Store: The Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details

For more information about this report visit https://www.researchandmarkets.com/r/3l5wcu

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900